July 20, 2016 / 12:22 PM / a year ago

BRIEF-Janssen says Health Canada approves Imbruvica for treatment of chronic lymphocytic leukemia

1 Min Read

July 20 (Reuters) - Johnson & Johnson :

* Health Canada approves Imbruvica (ibrutinib) for first-line treatment of chronic lymphocytic leukemia Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below